Tenet Healthcare Corporation cash flow to debt ratio of 26.88% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

Tenet Healthcare Corporation's free cash flow has increased 126.70% from $1.12B last year to $2.53B, signaling increasing performance

Tenet Healthcare Corporation's debt to equity ratio is 2.84, which means that the company's assets are unhealthy financed, signaling financial risk.

Tenet Healthcare Corporation's debt has decreased relative to shareholder equity from 3.43 last year to 2.84 today, signaling strengthened financials

Tenet Healthcare Corporation has a net debt to EBITDA ratio of 2.29x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

Tenet Healthcare Corporation's interest coverage ratio of 4.47 indicates that earnings with good margin can cover interest payments on company debt

Tenet Healthcare Corporation's profit margin has decreased (33.65%) in the last year from 15.49% to 10.27%, signaling decreasing performance

Tenet Healthcare Corporation's short-term assets of $7.85B exceed its short-term liabilities of $4.46B

Tenet Healthcare Corporation's return on assets of 7.31% is higher than the 5.00% threshold, indicating efficient asset utilization

Tenet Healthcare Corporation's return on equity of 50.63%, is higher than 15.00%, indicating good performance

Tenet Healthcare Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Tenet Healthcare Corporation had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Tenet Healthcare Corporation has positive free cash flow, indicating the company generates cash after capital expenditures

Tenet Healthcare Corporation has a free cash flow yield of 12.09%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Tenet Healthcare Corporation's yearly earnings has decreased 56.03% since last year from $3.20B to $1.41B, signaling decreasing performance

Tenet Healthcare Corporation's yearly revenue has increased 3.12% since last year from $20.66B to $21.31B, signaling increasing performance

ROIC 11.91% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.

Tenet Healthcare Corporation's 3-year revenue CAGR of 3.58% is positive, indicating growing revenue over the past 3 years

Tenet Healthcare Corporation had revenue growth in 4 out of 5 years, indicating consistent revenue performance

Tenet Healthcare Corporation had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Tenet Healthcare Corporation is overvalued relative to its fair value price of 186.43 based on Discounted Cash Flow model

Tenet Healthcare Corporation has an earnings yield of 10.32%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Tenet Healthcare Corporation is overvalued relative to its fair value price of 226.31 based on EBITDA multiple model

Tenet Healthcare Corporation has an EV/EBITDA ratio of 6.96x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Tenet Healthcare Corporation is undervalued relative to its fair value price of 479.98 based on Earnings Fair Value model

Tenet Healthcare Corporation has a PEG-ratio under 1 which is considered undervalued

Tenet Healthcare Corporation has a price-to-book ratio of 2.50x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Tenet Healthcare Corporation has a price-to-sales ratio of 1.00x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue